omniture

China Cord Blood Corporation to Announce Second Quarter Fiscal 2011 Financial Results

2010-11-17 19:16 1629

Earnings Call Scheduled for November 24, 2010

HONG KONG, Nov. 17, 2010 /PRNewswire-Asia/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or "the Company") today announced its plan to release financial results for the second quarter of fiscal year 2011 on Wednesday, November 24, 2010, before the market opens in the US.  

The Company will hold a teleconference at 8:00 a.m. ET on Wednesday, November 24, 2010 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session.  Interested parties may access the audio webcast through the following link: http://investor.chinacordbloodcorp.com/playerlink.zhtml?c=206671&s=wm&e=3489976.  A replay of the webcast will be accessible two hours after the presentation and available for three weeks at the same URL link above.  Listeners may also access the call by dialing 1-718-354-1231 or 1-866-519-4004 for US callers or +852-2475-0994 for Hong Kong callers, access code: 22793903.  

Supplemental financial information referenced in the conference call and the text of the second quarter press release can be found at http://www.chinacordbloodcorp.com, in the section titled Investor Center/Press Release, after 6:00 a.m. ET on the morning of the conference call.

Please dial in ten minutes prior to the conference to ensure proper connection and be prepared to provide your name and company to the operator.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with multiple licenses.  Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today.  China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services.  For more information, please visit our website at http://www.chinacordbloodcorp.com.  

For more information, please contact:




China Cord Blood Corporation


Ms. Joeling Law


Tel: (+852) 3605-8180


Email: ir@chinacordbloodcorp.com




ICR, LLC


In New York: Ashley M. Ammon or Christine Duan: 1-646-277-1227


In Beijing: Wen Lei Zheng: +86-10-6599-7968

Source: China Cord Blood Corporation
Related Stocks:
NYSE:CO
collection